BUSINESS Alkem Laboratories sees US FDA inspection at Taloja facility with no form 483 issued May 8, 2026
Alkem Laboratories sells Pithampur manufacturing facility to Rubicon Research for Rs 149 crore Jan 7, 2025
Alkem Laboratories to transfer trade generics business to Alkem Wellness for Rs 750 crore Dec 10, 2024
Alkem Laboratories Q2 FY25 Results: Revenue up 0.7% YoY to ₹3,414.67, Net Profit up 14.2% YoY Nov 13, 2024
Alkem Laboratories denies claims of its Pan-D and Clavam 625 products being not of standard quality Sep 27, 2024